Download PDF
The Journal of Hip Surgery 2021; 05(01): 001-006
DOI: 10.1055/s-0040-1722280
Original Article

Calcium and Vitamin D Supplementation in Osteoporosis and Fragility Hip Fracture Patients: A Retrospective NHANES Study

Evan D. Nigh 
1   Department of Orthopedic Surgery, Cedars-Sinai Medical Center, Los Angeles, California
,
Spencer H. Summers
2   Department of Orthopedic Surgery, Jackson Memorial Hospital, Miami, Florida
,
Duc M. Nguyen
2   Department of Orthopedic Surgery, Jackson Memorial Hospital, Miami, Florida
,
Sheila A. Conway
3   Department of Orthopedic Surgery, University of Miami Hospital, Miami, Florida
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Adequate vitamin D and calcium supplementation therapy in osteoporosis reduces the risk of fragility fractures and correlates with improved mortality outcomes in postoperative fragility hip fracture patients. However, the prevalence of adequate supplementation in this population remains unclear. Our purpose was to describe supplement use among the adult population in United States who have been told they had osteoporosis and identify factors associated with adequate supplementation, particularly in patients with history of hip fracture. The study sample comprised a total of 15,968 respondents from the National Health and Examinations Survey (NHANES 2007–2010, 2013–2014); 1,065 self-reported a diagnosis of osteoporosis and 266 self-reported a history of hip fracture. Additional patient factors were analyzed by multivariable logistic regression to assess associated factors of adequate vitamin D (≥ 600 international unit [IU]/day) and calcium (≥ 1000 mg/day) supplementation. The prevalence of vitamin D and calcium supplementation was significantly higher in the osteoporosis group than without (p = 0.001). However, supplemental intake reached adequate levels (≥ 600 IU/day of vitamin D and ≥ 1000mg/day of calcium) in only 28.8% of individuals with osteoporosis for vitamin D, 51.6% for calcium, and 19.2% for both. Of individuals with additional history of hip fracture, only 14% reported adequate intake of both nutrients. Female sex (odds ratio [OR]: 2.35, p < 0.001), older age (OR: 1.02, p < 0.001), and Caucasian race (OR: 1.456, p = 0.004) were positive factors of adequate supplementation, while Hispanic ethnicity was a negative factor (OR: 0.658, p = 0.009). Unexpectedly, a history of hip fracture did not affect the odds of adequate treatment (OR: 0.685, p = 0.176). Adults with known osteoporosis in the United States are self-reporting inadequate supplementation therapy, and significant gender and racial disparities exist. There is a broad need for improved supplementation to help manage this disease, particularly among adults with prior hip fracture, a vulnerable population most relevant for orthopaedic surgeons. This study serves as a call-to-action for orthopaedic surgeons to ensure their fragility hip fracture patients receive adequate supplementation postoperatively to maximize their health and recovery. This was a Level III, retrospective cohort study.

Keywords

osteoporosis - fragility hip fracture - vitamin supplementation


Publication History

Received: 25 August 2019

Accepted: 23 June 2020

Article published online:
21 January 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Mundi S, Pindiprolu B, Simunovic N, Bhandari M. Similar mortality rates in hip fracture patients over the past 31 years. Acta Orthop 2014; 85 (01) 54-59
    CrossrefPubMedGoogle Scholar
  • 2 van Geel TACM, Bliuc D, Geusens PPM. et al. Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: a prospective cohort study. PLoS One 2018; 13 (06) e0198006
    CrossrefPubMedGoogle Scholar
  • 3 Cree MW, Juby AG, Carriere KC. Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos Int 2003; 14 (09) 722-727
    CrossrefPubMedGoogle Scholar
  • 4 Schweser KM, Crist BD. Osteoporosis: a discussion on the past 5 years. Curr Rev Musculoskelet Med 2017; 10 (02) 265-274
    CrossrefPubMedGoogle Scholar
  • 5 Anagnostis P, Karras SN. Compliance with osteoporosis medications - an underestimated determinant of anti-fracture efficacy. Curr Med Res Opin 2015; 31 (05) 1015-1016
    CrossrefPubMedGoogle Scholar
  • 6 Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. J Intern Med 2006; 259 (06) 539-552
    CrossrefPubMedGoogle Scholar
  • 7 Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155 (12) 827-838
    CrossrefPubMedGoogle Scholar
  • 8 Cosman F, de Beur SJ, LeBoff MS. et al; National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int 2014; 25 (10) 2359-2381
    CrossrefPubMedGoogle Scholar
  • 9 Heinemann DF. Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide. Geriatrics 2000; 55 (05) 31-36 , quiz 39
    PubMedGoogle Scholar
  • 10 Weaver CM, Gordon CM, Janz KF. et al. The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int 2016; 27 (04) 1281-1386
    CrossrefPubMedGoogle Scholar
  • 11 Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293 (18) 2257-2264
    CrossrefPubMedGoogle Scholar
  • 12 Jackson RD, LaCroix AZ, Gass M. et al; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354 (07) 669-683
    CrossrefPubMedGoogle Scholar
  • 13 Weaver CM, Alexander DD, Boushey CJ. et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int 2016; 27 (01) 367-376
    CrossrefPubMedGoogle Scholar
  • 14 Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007; 370 (9588): 657-666
    CrossrefPubMedGoogle Scholar
  • 15 Bischoff HA, Stähelin HB, Dick W. et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003; 18 (02) 343-351
    CrossrefPubMedGoogle Scholar
  • 16 Nurmi-Lüthje I, Lüthje P, Kaukonen J-P. et al. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis. Drugs Aging 2009; 26 (05) 409-421
    CrossrefPubMedGoogle Scholar
  • 17 Doetsch AM, Faber J, Lynnerup N, Wätjen I, Bliddal H, Danneskiold-Samsøe B. The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo-controlled study. Calcif Tissue Int 2004; 75 (03) 183-188
    CrossrefPubMedGoogle Scholar
  • 18 Ross AC, Manson JE, Abrams SA. et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96 (01) 53-58
    CrossrefPubMedGoogle Scholar
  • 19 Chapuy MC, Pamphile R, Paris E. et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002; 13 (03) 257-264
    CrossrefPubMedGoogle Scholar
  • 20 Chapuy MC, Arlot ME, Duboeuf F. et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327 (23) 1637-1642
    CrossrefPubMedGoogle Scholar
  • 21 Harvey NC, Biver E, Kaufman J-M. et al. The role of calcium supplementation in healthy musculoskeletal ageing: an expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporos Int 2017; 28 (02) 447-462
    CrossrefPubMedGoogle Scholar
  • 22 Rotondi NK, Beaton DE, Sujic R. et al; Ontario Osteoporosis Strategy Fracture Clinic Screening Program Evaluation Team. Identifying and addressing barriers to osteoporosis treatment associated with improved outcomes: an observational cohort study. J Rheumatol 2018; 45 (11) 1594-1601
    CrossrefPubMedGoogle Scholar
  • 23 Sharman Moser S, Yu J, Goldshtein I. et al. Cost and consequences of nonadherence with oral bisphosphonate therapy: findings from a real-world data analysis. Ann Pharmacother 2016; 50 (04) 262-269
    CrossrefPubMedGoogle Scholar
  • 24 Dickinson A, MacKay D, Wong A. Consumer attitudes about the role of multivitamins and other dietary supplements: report of a survey. Nutr J 2015; 14 (01) 66
    CrossrefPubMedGoogle Scholar
  • 25 Pro-Risquez A, Harris SS, Song L, Rudicel S, Barnewolt B, Dawson-Hughes B. Calcium supplement and osteoporosis medication use in women and men with recent fractures. Osteoporos Int 2004; 15 (09) 689-694
    CrossrefPubMedGoogle Scholar
  • 26 Beaton DE, Sujic R, McIlroy Beaton K, Sale J, Elliot-Gibson V, Bogoch ER. Patient perceptions of the path to osteoporosis care following a fragility fracture. Qual Health Res 2012; 22 (12) 1647-1658
    CrossrefPubMedGoogle Scholar
  • 27 Miller AN, Lake AF, Emory CL. Establishing a fracture liaison service: an orthopaedic approach. J Bone Joint Surg Am 2015; 97 (08) 675-681
    CrossrefPubMedGoogle Scholar
  • 28 Statistics CNCfH. NHANES Survey Methods and Analytic Guidelines. . Updated February 21, 2020. Accessed July 9, 2020 at: https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx
    Google Scholar
  • 29 Alswat KA. Gender disparities in osteoporosis. J Clin Med Res 2017; 9 (05) 382-387
    CrossrefPubMedGoogle Scholar
  • 30 Wright NC, Saag KG, Curtis JR. et al. Recent trends in hip fracture rates by race/ethnicity among older US adults. J Bone Miner Res 2012; 27 (11) 2325-2332
    CrossrefPubMedGoogle Scholar
  • 31 Cawthon PM. Gender differences in osteoporosis and fractures. Clin Orthop Relat Res 2011; 469 (07) 1900-1905
    CrossrefPubMedGoogle Scholar
  • 32 Cauley JA. Defining ethnic and racial differences in osteoporosis and fragility fractures. Clin Orthop Relat Res 2011; 469 (07) 1891-1899
    CrossrefPubMedGoogle Scholar
  • 33 Liu Z, Weaver J, de Papp A. et al. Disparities in osteoporosis treatments. Osteoporos Int 2016; 27 (02) 509-519
    CrossrefPubMedGoogle Scholar
  • 34 Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 2003; 163 (18) 2165-2172
    CrossrefPubMedGoogle Scholar
  • 35 Wright NC, Looker AC, Saag KG. et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res 2014; 29 (11) 2520-2526
    CrossrefPubMedGoogle Scholar
  • 36 Curtis JR, McClure LA, Delzell E. et al. Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med 2009; 24 (08) 956-962
    CrossrefPubMedGoogle Scholar
  • 37 Vespa J, Armstrong DM, Medina LJW. Demographic turning points for the United States: population projections for 2020 to 2060. Washington, DC: US Department of Commerce, Economics and Statistics Administration, US Census Bureau; 2018
    Google Scholar
  • 38 Zingmond DS, Melton III LJ, Silverman SL. Increasing hip fracture incidence in California Hispanics, 1983 to 2000. Osteoporos Int 2004; 15 (08) 603-610
    CrossrefPubMedGoogle Scholar
  • 39 Lüthje P, Nurmi-Lüthje I, Kaukonen JP, Kuurne S, Naboulsi H, Kataja M. Undertreatment of osteoporosis following hip fracture in the elderly. Arch Gerontol Geriatr 2009; 49 (01) 153-157
    CrossrefPubMedGoogle Scholar
  • 40 Juby AG, De Geus-Wenceslau CM. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 2002; 13 (03) 205-210
    CrossrefPubMedGoogle Scholar
  • 41 Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM. Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am 2006; 88 (01) 25-34
    PubMedGoogle Scholar
  • 42 Miki RA, Oetgen ME, Kirk J, Insogna KL, Lindskog DM. Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial. J Bone Joint Surg Am 2008; 90 (11) 2346-2353
    CrossrefPubMedGoogle Scholar
  • 43 Gardner MJ, Brophy RH, Demetrakopoulos D. et al. Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial. J Bone Joint Surg Am 2005; 87 (01) 3-7
    CrossrefPubMedGoogle Scholar
  • 44 Sheehan J, Mohamed F, Reilly M, Perry IJ. Secondary prevention following fractured neck of femur: a survey of orthopaedic surgeons practice. Ir Med J 2000; 93 (04) 105-107
    PubMedGoogle Scholar
  • 45 Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 2004; 15 (10) 767-778
    CrossrefPubMedGoogle Scholar
  • 46 Anderson-Wurf J, McGirr J, Seal A, Harding C. Orthopedic surgeons' attitudes to osteoporosis investigation and management after minimal trauma fracture (MTF). Arch Osteoporos 2017; 12 (01) 2
    CrossrefPubMedGoogle Scholar
  • 47 Bunta AD, Edwards BJ, Macaulay Jr WB. et al. Own the bone, a system-based intervention, improves osteoporosis care after fragility fractures. J Bone Joint Surg Am 2016; 98 (24) e109
    CrossrefPubMedGoogle Scholar